According to Fortune Business Insights, The global adherence packaging market was valued at USD 1.13 billion in 2024 and is anticipated to grow to USD 1.20 billion in 2025, eventually reaching USD 1.89 billion by 2032. This growth reflects a CAGR of 6.67% over the forecast period. In 2024, North America led the market, accounting for 38.05% of the global share.
Adherence packaging is a pharmacy service that organizes a patient’s medications into personalized pouches or blister packs aligned with their dosing schedule. Its primary purpose is to improve medication adherence and, as a result, clinical outcomes. Demand for these solutions is rising—particularly among older adults and people with chronic conditions—and is being further propelled by innovations such as smart packaging and the integration of digital health technologies, which are expanding the global market. Adherence packaging, also called compliance packaging means the method of packaging that makes the adherence of patients to their drug routine easy. The surge in the emphasis of prominent companies on the enhancement of medication adherence through more patient-focused and intelligent packaging methods, which leads to the generation of data from current delivery systems and medicines while aiding in the reduction of wastage of drugs, is fostering the market growth.
Fortune Business Insights presents this information in their report titled " Adherence Packaging Market, 2025–2032."
WestRock Company (U.S.)
Manrex Limited (Canada)
Parata Systems LLC (U.S.)
McKesson Corporation (U.S.)
Pearson Medical Technologies LLC (U.S.)
Cardinal Health, Inc. (U.S.)
Omnicell, Inc. (U.S.)
Becton, Dickinson, and Company (U.S.)
Talyst, LLC (U.S.)
TCGRx (U.S.)
By material, the market is classified into aluminum, paper & paperboard, and plastic. The plastic segment captured the largest adherence packaging market share in 2023. This can be attributed to the cost-effectiveness, transparency, lightweight, and malleable nature of plastic.
In terms of type, the market is bifurcated into multi-dose and unit-dose. The multi-dose segment accounts for the largest share due to the growing requirement for adherence to medication.
Based on packaging type, the market is segregated into pouches and blisters. The blisters segment holds the largest market share. Enhanced shelf-life, ease of transport, and high resistance to tamper provided by blisters are augmenting the segment expansion.
With respect to end users, the market for adherence packaging is segmented into long-term care facilities, pharmacies, and hospitals.
Geographically, the market is divided into the Asia Pacific, Latin America, the Middle East & Africa, Europe, and North America.
The research report provides a detailed analysis of the major strategic initiatives opted for by leading players in the market. In addition, it highlights the top trends, key industry developments, and the impact of the COVID-19 pandemic on the market growth. Additional aspects of the report include the notable factors impacting the adherence packaging market size.
The adherence packaging market growth can be credited to a rise in desire for the removal of wastage of the drug. Moreover, medication waste accounts for a substantial impact on the economy and the healthcare system across the globe and creates detrimental consequences for the environment.
North America accounts for the dominating position in the market. This is due to the growing spending power on healthcare coupled with the surging medical research & life science research activities.
Europe is the second-leading region in the adherence packaging market owing to the heightened availability of government funding for activities pertaining to research and development.
The Asia Pacific market is observing the fastest growth owing to the growing uptake of the solution along with healthcare sector investments.
Mergers & acquisitions, partnerships, and joint ventures are some of the strategies opted for by leading companies to gain a competitive edge in the adherence packaging market. Several firms are also focusing on launching new products to sustain their industry leadership.
In April 2024, Gerresheimer partnered with U.S. digital health company RxCap, acquiring a minority stake. Gerresheimer's subsidiary Center aimed at distributing RxCap's adherence solutions in U.S. pharmacies, leveraging its market leadership in prescription vials to enhance pharmacy workflows with smart technology.
In April 2024, Jones Healthcare Group launched a new line of smart adherence packages that utilizes technology to monitor medication usage and enhance patient engagement.